FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 15 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,820,000 | -4.2% | 4,000,000 | 0.0% | 0.24% | -10.7% |
| Q4 2022 | $1,900,400 | -32.1% | 4,000,000 | 0.0% | 0.27% | -19.3% |
| Q3 2022 | $2,800,000 | -14.4% | 4,000,000 | +6.4% | 0.34% | +50.4% |
| Q2 2022 | $3,272,000 | -21.0% | 3,760,508 | +1.6% | 0.22% | +19.1% |
| Q1 2022 | $4,144,000 | +37.4% | 3,700,000 | +143.0% | 0.19% | +3.3% |
| Q4 2021 | $3,015,000 | -19.6% | 1,522,859 | +38.4% | 0.18% | -20.9% |
| Q3 2021 | $3,751,000 | -38.6% | 1,100,000 | +46.7% | 0.23% | -30.9% |
| Q2 2021 | $6,113,000 | -33.7% | 750,000 | 0.0% | 0.33% | -49.5% |
| Q1 2021 | $9,225,000 | -32.6% | 750,000 | 0.0% | 0.66% | -28.1% |
| Q4 2020 | $13,695,000 | +20.2% | 750,000 | +2.7% | 0.92% | -12.2% |
| Q3 2020 | $11,395,000 | – | 730,000 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 1,379,843 | $11,246,000 | 2.62% |
| Novo Holdings A/S | 2,361,229 | $19,244,000 | 0.85% |
| Ally Bridge Group (NY) LLC | 401,747 | $3,274,000 | 0.81% |
| SECTORAL ASSET MANAGEMENT INC | 640,714 | $5,222,000 | 0.42% |
| FRAZIER MANAGEMENT LLC | 550,000 | $4,483,000 | 0.41% |
| TFG Asset Management GP Ltd | 750,000 | $6,113,000 | 0.33% |
| Eventide Asset Management | 2,485,656 | $19,757,000 | 0.26% |
| AXA S.A. | 1,111,510 | $9,058,000 | 0.01% |
| Woodline Partners LP | 25,932 | $211,000 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 2,001,951 | $16,315,000 | 0.00% |